Canada's Iogen will shift its attention to cellulosic ethanol production after agreeing to sell its industrial enzyme operations to Novozymes for about $80 million. "We're fully focused on making cellulosic ethanol a big success," said Iogen CEO Brian Foody. Proceeds from the sale of Iogen's Bio-Products unit will be used for debt repayment, Foody said.

Related Summaries